JAGX (Jaguar Health) Float Percentage Of Total Shares Outstanding: 100.01% (As of Jul. 25, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

JAGX Jaguar Health Inc JAGX
21 GF Score
Price $0.96
! 3 Warning Signs
View Full Analysis

What is Jaguar Health Float Percentage Of Total Shares Outstanding?

Jaguar Health JAGX -6.48% 21 Float Percentage Of Total Shares Outstanding is 100.01% as of Jul. 25, 2026. GuruFocus rates JAGX with a GF Score™ of 21/100. The stock has 3 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Jaguar Health's float shares is 4.91 Mil. Jaguar Health's total shares outstanding is 4.91 Mil. Jaguar Health's float percentage of total shares outstanding is 100.01%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Jaguar Health's Insider Ownership is 1.99%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Jaguar Health's Institutional Ownership is 1.43%.

JAGX
21GF Score
Jaguar Health Inc JAGX
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jaguar Health Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Jaguar Health's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=4.91/4.91
=100.01%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 100.01% mean?
Jaguar Health (JAGX) has a Float Percentage Of Total Shares Outstanding of 100.01% as of Jul. 25, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Jaguar Health and its competitors.
Is Jaguar Health's Float Percentage Of Total Shares Outstanding too high?
Jaguar Health's current Float Percentage Of Total Shares Outstanding is 100.01%. Overall, Jaguar Health has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Jaguar Health's Float Percentage Of Total Shares Outstanding compare to MBRX and BCDA?
Jaguar Health's Float Percentage Of Total Shares Outstanding of 100.01% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Jaguar Health and its competitors. Jaguar Health's current Float Percentage Of Total Shares Outstanding is 100.01%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jaguar Health stock overvalued right now?
Jaguar Health (JAGX) has a current Float Percentage Of Total Shares Outstanding of 100.01%. The current Float Percentage Of Total Shares Outstanding is 100.01%. Jaguar Health's overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Jaguar Health (JAGX), the current Float Percentage Of Total Shares Outstanding is 100.01% as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Jaguar Health Business Description

Address 200 Pine Street, Suite 400, San Francisco, CA, USA, 94104
Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.
21GF Score

Get the complete analysis for JAGX

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.96
Price